LGE and NT-proBNP identify low risk of death or arrhythmic events in patients with primary prevention ICDs

JACC: Cardiovascular Imaging

Volumn 7, Issue 6, 2014, Pages 561-569

  Mordi, Ify ^a   Jhund, Pardeep S ^a   Gardner, Roy S ^b   Payne, John ^b   Carrick, David ^a   Berry, Colin ^a,b   Tzemos, Nikolaos ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

death; implantable cardioverter defibrillator (ICD); MRI; natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GADOLINIUM PENTETATE; SPIRONOLACTONE; BRAIN NATRIURETIC PEPTIDE; GADOLINIUM; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIMARY PREVENTION; PRIORITY JOURNAL; TREATMENT OUTCOME; BLOOD; IMAGE ENHANCEMENT; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT;

DEFIBRILLATORS, IMPLANTABLE; FEMALE; GADOLINIUM; HEART FAILURE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PRIMARY PREVENTION; RISK ASSESSMENT;

EID: 84902261936     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.12.014     Document Type: Article

References (31)

1. A.J. Moss, W. Zareba, and W.J. Hall et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
2. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
3. A.J. Moss, H. Greenberg, and R.B. Case et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator Circulation 110 2004 3760 3765
4. E.C. Stecker, C. Vickers, and J. Waltz et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study J Am Coll Cardiol 47 2006 1161 1166
5. P. Bernhardt, S. Stiller, and E. Kottmair et al. Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up Int J Cardiovasc Imaging 27 2011 893 900
6. P. Gao, R. Yee, and L. Gula et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging Circ Cardiovasc Imaging 5 2012 448 456
7. L. Iles, H. Pfluger, and L. Lefkovits et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter- defibrillators for primary prevention of sudden cardiac death J Am Coll Cardiol 57 2011 821 828
8. R.Y. Kwong, A.K. Chan, and K.A. Brown et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743
9. P.A. Scott, J.M. Morgan, and N. Carroll et al. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators Circ Arrhythm Electrophysiol 4 2011 324 330
10. K.C. Wu, R.G. Weiss, and D.R. Thiemann et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421
11. R.G. Assomull, S.K. Prasad, and J. Lyne et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
12. P.A. Scott, P.A. Townsend, and L.L. Ng et al. Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkers Europace 13 2011 1419 1427
13. L.M. Biasucci, F. Bellocci, and M. Landolina et al. Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the Cami-Guide study Eur Heart J 33 2012 1344 1350
14. R. Berger, M. Huelsman, and K. Strecker et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
15. A.R. Payne, M. Casey, and J. McClure et al. Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage Circ Cardiovasc Imaging 4 2011 210 219
16. R.S. Gardner, K.S. Chong, J.J. Morton, and T.A. McDonagh A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure Eur J Heart Fail 9 2007 266 271
17. M.R. Bristow, L.A. Saxon, and J. Boehmer et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
18. D.R. Bolick, D.B. Hackel, K.A. Reimer, and R.E. Ideker Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia Circulation 74 1986 1266 1279
19. D.H. Kwon, C.M. Halley, and T.P. Carrigan et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study J Am Coll Cardiol Img 2 2009 34 44
20. S.D. Roes, C.J. Borleffs, and R.J. van der Geest et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator Circ Cardiovasc Imaging 2 2009 183 190
21. S. de Haan, T.A. Meijers, P. Knaapen, A.M. Beek, A.C. van Rossum, and C.P. Allaart Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models Heart 97 2011 1951 1956
22. S.J. Pocock, D. Wang, and M.A. Pfeffer et al. Predictors of mortality and morbidity in patients with chronic heart failure Eur Heart J 27 2006 65 75
23. A. Maisel, C. Mueller, and K. Adams Jr. et al. State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
24. H. Wedel, J.J. McMurray, and M. Lindberg et al. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide Eur J Heart Fail 11 2009 281 291
25. S. Masson, R. Latini, and I.S. Anand et al. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-Heft (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
26. P.A. Scott, J. Barry, P.R. Roberts, and J.M. Morgan Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis Eur J Heart Fail 11 2009 958 966
27. A. Verma, F. Kilicaslan, and D.O. Martin et al. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies Heart 92 2006 190 195
28. D.S. Lee, A.D. Krahn, and J.S. Healey et al. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database J Am Coll Cardiol 55 2010 774 782
29. K.C. Wu, G. Gerstenblith, and E. Guallar et al. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death Circ Cardiovasc Imaging 5 2012 178 186
30. J.J. Germano, M. Reynolds, V. Essebag, and M.E. Josephson Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 97 2006 1255 1261
31. A.S. Flett, J. Hasleton, and C. Cook et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance J Am Coll Cardiol Img 4 2011 150 156